J0278Amikacin sulfate injection
Published CMS Medicare Part B payment-limit context for J0278, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$0.614
per 100 MG · Medicare Part B
Up 0.7%from $0.61 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$0.8011$0.5079
2024-Q4: $0.769; 2025-Q1: $0.54; 2025-Q2: $0.601; 2025-Q3: $0.617; 2025-Q4: $0.633; 2026-Q1: $0.621; 2026-Q2: $0.61; 2026-Q3: $0.614
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Amikacin Sulfate ingredient family (FDA data as of August 20, 2026).
Amikacin Sulfate
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.